TP53 and cancer: Clearly, loss of p53, seen in many cancers, will ultimately preclude the activation of a set of cell death and cell cycle arrest regulators, facilitating the escape of such micronucleated tetraploid G1 cells, promoting the selection of more complex karyotypes culminating in aneuploidy tolerance, a major drive of tumor evolution (Fig 2).